| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |